These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9721706)

  • 1. Natural history of colorectal carcinoma: can the tumor volume doubling time be predicted by radiologic findings or immunohistochemical variables?
    Iwashita I; Ueyama T; Iwashita A; Kawamoto K; Kitagawa S; Motooka M; Utsunomiya T; Masuda K
    J Surg Oncol; 1998 Aug; 68(4):215-24. PubMed ID: 9721706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
    Georgescu CV; Săftoiu A; Georgescu CC; Ciurea R; Ciurea T
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
    Martín R; Nieto S; Santamaría L
    Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of proliferative activities and metastases between two subtypes classified at the deeply infiltrating sites of colorectal moderately differentiated adenocarcinomas.
    Taniyama K; Sasaki N; Wada S; Sasaki M; Miyoshi N; Nakai H; Kodama S; Nakatsuka H; Tahara E
    Pathol Int; 1996 Mar; 46(3):195-203. PubMed ID: 10846570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
    De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
    Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of the standardized uptake value in FDG-PET with the expression level of cell-cycle-related molecular biomarkers in resected non-small cell lung cancers.
    Nakamura H; Hirata T; Kitamura H; Nishikawa J
    Ann Thorac Cardiovasc Surg; 2009 Oct; 15(5):304-10. PubMed ID: 19901884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between cyclin B1 overexpression and lymph node metastasis in human colorectal cancer.
    Korenaga D; Takesue F; Yasuda M; Honda M; Nozoe T; Inutsuka S
    Surgery; 2002 Jan; 131(1 Suppl):S114-20. PubMed ID: 11821797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas.
    Choi HJ; Jung IK; Kim SS; Hong SH
    Dis Colon Rectum; 1997 Jan; 40(1):51-9. PubMed ID: 9102262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung.
    Demarchi LM; Reis MM; Palomino SA; Farhat C; Takagaki TY; Beyruti R; Saldiva PH; Capelozzi VL
    Mod Pathol; 2000 May; 13(5):511-20. PubMed ID: 10824922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of p53, p21WAF1/C1PI, and bcl-2 in radioresistant colorectal carcinoma.
    Palazzo JP; Kafka NJ; Grasso L; Chakrani F; Hanau C; Cuesta KH; Mercer WE
    Hum Pathol; 1997 Oct; 28(10):1189-95. PubMed ID: 9343326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and immunoexpression of p53, MIB-1 and proliferating cell nuclear antigen in adrenal neoplasms.
    Martins AC; Cologna AJ; Tucci S; Suaid HJ; Falconi RA
    J Urol; 2005 Jun; 173(6):2138-42. PubMed ID: 15879867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers.
    Haitel A; Wiener HG; Blaschitz U; Marberger M; Susani M
    Cancer; 1999 Apr; 85(7):1593-8. PubMed ID: 10193951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micropapillary component in colorectal carcinoma is associated with lymph node metastasis in T1 and T2 Stages and decreased survival time in TNM stages I and II.
    Xu F; Xu J; Lou Z; Di M; Wang F; Hu H; Lai M
    Am J Surg Pathol; 2009 Sep; 33(9):1287-92. PubMed ID: 19471152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
    Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
    Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 expression in colorectal tumours. Correlation with p53, mdm-2, Rb proteins and proliferation indices.
    Goussia AC; Ioachim E; Agnantis NJ; Mahera M; Tsianos EV
    Histol Histopathol; 2000 Jul; 15(3):667-72. PubMed ID: 10963109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferating cell nuclear antigen (PCNA) in relation to ras, c-erbB-2,p53, clinico-pathological variables and prognosis in colorectal adenocarcinoma.
    Sun XF; Carstensen JM; Stål O; Zhang H; Nordenskjöld B
    Int J Cancer; 1996 Feb; 69(1):5-8. PubMed ID: 8600060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective radiographic analysis of nonpedunculated colorectal carcinomas with special reference to tumor doubling time and morphological change.
    Umetani N; Masaki T; Watanabe T; Sasaki S; Matsuda K; Muto T
    Am J Gastroenterol; 2000 Jul; 95(7):1794-9. PubMed ID: 10925987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cyclo-oxygenase-2 and p53 immunoreactivity in superficial early colorectal carcinoma].
    Kim YS; Lim SD; Lee JK; Kim SE; Ryu SH; Lee JW; Moon JS
    Korean J Gastroenterol; 2006 May; 47(5):350-6. PubMed ID: 16714876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
    Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.